Contract Awards Details
Ref No 16050384
Document

Contract Awards

Bidding

Not specified

Contract Details

Direct Adjustment For The Acquisition Of I287- Infliximab Patients Under Treatment [100 Mg; Powder P/A Conc To Sol P/A Perf; Frs], U41- Ustecinumab [45 Mg/ 0.5 Ml; Sol Inj; Syringe] - Patients In Treatment, U42- Ustecinumab [90 Mg; Sol Inj; Syringe] - Patients In Treatment And U43- Ustecinumab [130 Mg; Sol Inj; Frs] - Patients In Treatment.

Contract Completion *
Date 05 Aug 2025
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Portugal
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Contracts Awards

Used Container According To Memory

Acquisition Of Various Articles For Neonatology

Castration Including Aftercare Of Stray Cats Living In The Wild